UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000036403
Receipt number R000041470
Scientific Title Non-invasive marker to predict the remission of diabetic kidney disease for well-managed diabetic patient-2.
Date of disclosure of the study information 2019/04/05
Last modified on 2022/10/05 14:27:16

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Non-invasive marker to predict the remission of diabetic kidney disease for well-managed diabetic patient-2.

Acronym

DKDrem-2

Scientific Title

Non-invasive marker to predict the remission of diabetic kidney disease for well-managed diabetic patient-2.

Scientific Title:Acronym

DKDrem-2

Region

Japan


Condition

Condition

Diabetic Kidney Disease

Classification by specialty

Endocrinology and Metabolism Nephrology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Establishment of the non-invasive marker to predict the effectiveness of control of multiple risk factors for improving diabetic kidney disease

Basic objectives2

Others

Basic objectives -Others

Establishment of the method of evaluating the effect of the treatment for improving diabetic kidney disease

Trial characteristics_1

Confirmatory

Trial characteristics_2

Pragmatic

Developmental phase

Not applicable


Assessment

Primary outcomes

Deceleration of the rate of eGFR(estimated glomerular filtration rate) decline

Key secondary outcomes

the rate of eGFR(estimated glomerular filtration rate) decline


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

(1)type 2 diabetic patients
(2)eGFR(estimated glomerular filtration rate)<60ml/min/1.73m2 or urinary albumin creatinine ratio>30mg/g Cr
(3)patients followed-up for more than 3 months

Key exclusion criteria

(1)pregnancy
(2)malignant tumors
(3)patients having the history of cerebral infarction within 1 year prior to obtaining consent.
(4)severe orthostatic hypotension
(5)chronic urinary tract infection
(6)congestive heart failure
(7)neurogenic bladder
(8)nondiabetic kidney disease
(9)severe emaciation (BMI<18kg/m2)
(10)endstage renal disease

Target sample size

500


Research contact person

Name of lead principal investigator

1st name Motonobu
Middle name
Last name Nihsimura

Organization

National Hospital Organization Chibahigashi National Hospital

Division name

Department of Diabetes and Endocrinology

Zip code

260-8712

Address

673, Nitonatyou, Tyuuou-ku, Chiba city, Chiba, 260-8712, Japan

TEL

043-261-5171

Email

nishimura.motonobu.ky@mail.hosp.go.jp


Public contact

Name of contact person

1st name Motonobu
Middle name
Last name Nishimura

Organization

National Hospital Organization Chibahigashi National Hospital

Division name

Department of Diabetes and Endocrinology

Zip code

260-8712

Address

673, Nitonatyou, Tyuuou-ku, Chiba city, Chiba, 260-8712, Japan

TEL

043-261-5171

Homepage URL


Email

nishimura.motonobu.ky@mail.hosp.go.jp


Sponsor or person

Institute

National Hospital Organization

Institute

Department

Personal name



Funding Source

Organization

National Hospital Organization

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

National Hospital Organization

Address

2-5-21, Higashigaoka, Meguro-ku, Tokyo

Tel

03-5712-5075

Email

700-kenkyu@mail.hosp.go.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

国立病院機構千葉東病院(千葉県)、国立病院機構函館病院(北海道)、国立病院機構渋川医療センター(群馬県)、国立病院機構三重中央医療センター(三重県)、国立病院機構京都医療センター(京都府)、国立病院機構岡山医療センター(岡山県)、国立病院機構大阪医療センタ(大阪府)、国立病院機構兵庫中央病院(兵庫県)、国立病院機構姫路医療センター(兵庫県)、国立病院機構呉医療センター(広島県)、国立病院機構東広島医療センター(広島県)、国立病院機構米子医療センター(鳥取県)、国立病院機構徳島病院(徳島県)、 国立病院機構鹿児島医療センター(鹿児島県)


Other administrative information

Date of disclosure of the study information

2019 Year 04 Month 05 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

233

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

No longer recruiting

Date of protocol fixation

2018 Year 09 Month 25 Day

Date of IRB

2018 Year 09 Month 25 Day

Anticipated trial start date

2018 Year 11 Month 01 Day

Last follow-up date

2023 Year 03 Month 31 Day

Date of closure to data entry

2023 Year 06 Month 30 Day

Date trial data considered complete

2023 Year 09 Month 30 Day

Date analysis concluded

2024 Year 03 Month 31 Day


Other

Other related information

The method of registration of the patients (the patients who visited the participating institutions during April 2006 through October 2019, fulfilled the criteria)
Outcome assessment (serum creatinine level, urinary albumin excretion rate, urinary protein excretion rate, HbA1c, LDL-cholesterol, clinic blood pressure, home blood pressure, renal ultrasonography, urinary podocyte, serum thrombomodulin, serum erythropoietin, ect)


Management information

Registered date

2019 Year 04 Month 03 Day

Last modified on

2022 Year 10 Month 05 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000041470